iBio (IBIO) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for iBio (IBIO) over the last 10 years, with Q4 2025 value amounting to -$0.09.
- iBio's EPS (Weighted Average and Diluted) rose 8125.0% to -$0.09 in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.0, marking a year-over-year decrease of 4925.37%. This contributed to the annual value of -$1.75 for FY2025, which is 2914.6% up from last year.
- Latest data reveals that iBio reported EPS (Weighted Average and Diluted) of -$0.09 as of Q4 2025, which was up 8125.0% from -$0.11 recorded in Q3 2025.
- In the past 5 years, iBio's EPS (Weighted Average and Diluted) ranged from a high of $0.01 in Q2 2021 and a low of -$68.43 during Q4 2022
- Its 5-year average for EPS (Weighted Average and Diluted) is -$5.11, with a median of -$1.02 in 2024.
- In the last 5 years, iBio's EPS (Weighted Average and Diluted) tumbled by 3010365.36% in 2022 and then surged by 9354.08% in 2023.
- Over the past 5 years, iBio's EPS (Weighted Average and Diluted) (Quarter) stood at -$1.37 in 2021, then crashed by 4894.89% to -$68.43 in 2022, then surged by 93.54% to -$4.42 in 2023, then soared by 89.14% to -$0.48 in 2024, then skyrocketed by 81.25% to -$0.09 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.09 in Q4 2025, compared to -$0.11 in Q3 2025 and -$0.49 in Q2 2025.